Skip to main content

Patient Care

Kingston General Hospital, a 446-bed teaching and referral hospital, delivers quality tertiary care in the academic setting of Queen's University. As the only tertiary care Centre in this region of southeastern Ontario, we have a large referral base encompassing the area between Belleville and Brockville, and Smith Falls to Lake Ontario. This translates to a referral population base of about 600,000.


  • Outpatient Urology Clinic - Hotel Dieu Hospital, Jeanne Mance 4 (613-544-3400 X####)
  • Outpatient Cystoscopy Clinic - Hotel Dieu Hospital, Johnson 4 (613-544-3400 X####)
  • Urodynamics and Biofeedback - Hotel Dieu Hospital, Johnson 4 (613-544-3400 X####)
  • Center for Applied Urological Research (CAUR) - 62 Barrie Street, Kingston ON
  • Kingston Regional Bladder Center - Lennox and Addington County General Hospital
  • Cancer Clinic - Cancer Center of Southeastern Ontario, Level 1
  • Napanee Urology Clinic - Lennox and Addington County General Hospital
  • Vasectomy Clinic - Kingston General Hospital, Armstrong 1
  • Urgent Urology Outpatient Clinic - Kingston General Hospital, Armstrong 1

Our department has the good fortune of operating within Queen’s University, and as such you are certain to encounter trainees throughout your experience with us in the clinic, operating room, and inpatient wards. We are a Royal College of Physicians and Surgeons postgraduate urology training program, and an active department in the School of Medicine within Queen’s Faculty of Health Sciences.

We consider our patients fortunate to have the opportunity to participate in the education of our trainees, who provide careful and skilled clinical evaluations and essential support in the operating room to the attending urologists. The attending urologist remains responsible for your overall care. We are always supportive of the mutual benefits of having trainees involved in patient care.

Participant Testimonials


Throughout my life, I have always lived a healthy lifestyle and felt I had kept myself in good physical condition.

Therefore, I was completely shocked to be diagnosed with bladder cancer in 2018 at the age of 49. 

I was informed I had an aggressive type of cancer and would require 2 surgeries as well as 6 follow up BCG treatments in an effort to stop the growth and spread. 

After my successful surgeries I was approached by two representatives of the Center for applied urological research, Kassidy Rideout and Angela Black, about participating in a drug trial for research and possibly to offset the chance of reoccurrence.

 They sat down and fully explained the process to my wife and I with such knowledge, kindness and understanding of what we were going through that we chose to participate.

At a very confused and stressed time in my life I realize now just how fortunate I was to have met these two ladies that day. 

The care and support I received from Kassidy, Angie and the entire urological team in Kingston was absolutely amazing. 

I would strongly encourage anyone to participate in any research trial offered by the Centre for Applied Urological Research.

I have been a patient of the CAUR for over 8 years.

During that time, the Centre has monitored my PSA readings and provided hormonal therapy as required.  Aside from dealing with Dr’s. Wilson and Izard, I have received excellent and timely care from Angela Black.  Angela has always kept me fully informed as to the treatments being provided, the reasons for them and likely outcomes.  In addition, she has always been caring and kind.

During the 8 years, I have participated in two research studies.  These studies had clear objectives that were clearly described to me.  I always felt that the studies were extremely worthwhile.  While participating in the research, I always knew that my needs as a patient were the paramount consideration.  I will gladly participate in any further research that the Centre might undertake.

As a graduate and former faculty member at Queen’s University, I am proud that we have this Centre on campus.  I am confident that it will contribute to developing future, effective treatments for urological patients.